At OCTSC, an expert delved into how to optimise patient enrollment to achieve retention and clinical trial success.
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has directed Abbott ...
As artificial intelligence (AI) use continues to grow in nearly every industry, it is important to establish guardrails to ...
Provides clarity on the aspects to incorporate Company to address them and resubmit revised protocol MADRID, Spain and CAMBRIDGE, Mass., Oct.
"Sponsors should design failure into clinical trials to support patients" was originally created and published by Clinical ...
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has opined that Novo Nordisk ...
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient’s own) stem cell therapy company offering VesCell™ ...
A New York Times health reporter explains what makes a good study, and how she knows which papers merit an article.
CDMO conglomerate Almac is pouring $48 million into its eClinical offering via an investment that includes the launch of a ...
Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Biorasi, a global clinical ...
Hamad Medical Corporation (HMC) has signed a Memorandum of Understanding (MoU) with AbbVie Biopharmaceuticals Gulf Levant to ...
Adoption of Datatrak's eClinical solution enables CRO to actively manage all clinical trial data, processes, and documents on a single platform and dashboard with the first true eSource solution that ...